Tag: Sun Pharmaceutical Industries Ltd.

Nafamostat identified as a potential candidate for Covid-19 patients by scientists at University of Tokyo and Leibniz Institute for Primate ...

Relationship gives Sun Pharma access to Greater China market for Tildrakizumab China to become a key market in future with ...

First Trial of ILUMYA™ in Patients with Psoriatic Arthritis Met Primary Efficacy Endpoint, with No Evident Safety Concerns Over 71% ...